Loading…
Grünenthal acquired Kyowa Kirin International's 49% stake in Grünenthal Meds, taking full ownership of the joint venture and its portfolio of 12 established medicine brands with €170 million in revenue.
Grünenthal announced the opening of a new women's health products plant in Peñalolén, Chile, with an investment of USD 14.5 million. The facility is the company's center of excellence for hormone production and the most modern in Latin America.
| Site | Largest | Latest |
|---|---|---|
| Peñalolén, Chile | $14.5M | 2017-01-16 |